# Coinbase stock Sell rating reiterated as CFTC expands US crypto

**Published:** 2026-07-18T17:44:42.022Z  
**Topic:** Coinbase  
**Sentiment:** neutral  
**Publisher:** TrendWatcher — https://www.trendwatcher.in/article/954622d4-501c-4684-bdf4-53edeb445413

Compass Point keeps its Sell rating on Coinbase, setting a $140 target after CFTC's May 29 derivatives expansion, citing competition and regulatory risk.

Coinbase shares slipped to $180.86, a 27% drop over six months, as Compass Point reaffirmed its Sell rating and $140 price target, warning that the CFTC’s recent move to broaden U.S. crypto derivatives could curb the exchange’s revenue growth and market share [1].

| At a glance | |
|---|---|
| Price | $180.86 |
| 6‑month change | –27% |
| Target | $140 |
| Catalyst | CFTC expands crypto derivatives (May 29) |

## Derivatives expansion drives the bearish outlook  
The CFTC announced on May 29 that it will allow new crypto derivative products, including Kalshi’s Bitcoin perpetual futures and Deribit’s offshore contracts for U.S. users, while CME will move to 24/7 crypto futures trading [1]. Compass Point argues that these additions will intensify competition for Coinbase, whose own perpetual‑futures revenue was only $50 million in the latest quarter and whose spot‑trading commissions are already being eroded by existing futures products. The firm expects low switching costs and the potential approval of rivals such as Hyperliquid or Binance to limit Coinbase’s pricing power, especially among sophisticated traders who dominate the perpetual market [2].

## Competitive pressures and valuation concerns  
Beyond regulatory headwinds, Compass Point points to a crowded field of U.S. and offshore platforms—Kraken, Robinhood, Interactive Brokers, and BULL have already integrated with Kalshi, while Binance settled a $4.3 billion U.S. case in 2023, positioning it for possible market entry [2]. The analyst notes that Coinbase’s $2.9 billion acquisition of Deribit last year does not shield it from these dynamics. With the stock trading at a 63.4‑times earnings multiple, the firm deems it overvalued at current levels, reinforcing the Sell stance and the $140 target, which represents a further 22% decline from today’s price [1].

## Market sentiment and analyst divergence  
Compass Point’s bearish view aligns with broader analyst sentiment: nine analysts have cut earnings forecasts for Coinbase’s upcoming period, according to InvestingPro data [1]. However, other houses remain optimistic—Benchmark raised its target to $270 and Canaccord Genuity to $300—citing market‑share gains in derivatives and prediction markets. The split underscores the uncertainty surrounding how U.S. regulatory actions will reshape revenue streams for crypto exchanges.

## What to watch  
- CFTC decisions on permitting offshore platforms like Binance or Hyperliquid to operate in the U.S. (any new rulings could impact Coinbase’s market share).  
- Coinbase’s quarterly revenue from perpetual futures versus spot trading (a widening gap would reinforce the Sell thesis).  
- Movements in Coinbase’s stock around the $150 support level and the $140 target price.

Compass Point’s reiteration highlights the twin challenges of tighter U.S. regulatory oversight and a rapidly evolving derivatives landscape, leaving Coinbase’s ability to sustain growth and pricing power in question. The next regulatory or competitive development will likely determine whether the stock can recover toward its higher analyst targets or slide closer to the $140 outlook.

## Sources
1. Investing — [Compass Point reiterates Coinbase stock Sell rating on ...](https://www.investing.com/news/analyst-ratings/compass-point-reiterates-coinbase-stock-sell-rating-on-derivatives-expansion-93CH-4719881)
2. Finobird — [Compass Point Reiterates Sell Rating on Coinbase Citing ...](https://finobird.com/stories/compass-point-analysts-reiterate-a-sell-rating-on-coinbase-warning-of-intense-co/)

---
Cite as: TrendWatcher, "Coinbase stock Sell rating reiterated as CFTC expands US crypto", https://www.trendwatcher.in/article/954622d4-501c-4684-bdf4-53edeb445413